Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection-Reference-Cited by-同舟云学术

Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection

Published:2022-02-09 Issue:5 Volume:116 Page:297-304
ISSN:2047-7724
Container-title:Pathogens and Global Health
language:en
Short-container-title:Pathogens and Global Health

Author:

Bavaro DF¹,Diella L¹,Solimando AG²^ORCID,Cicco S²,Buonamico E³,Stasi C⁴,Ciannarella M⁴,Marrone M⁵,Carpagnano F⁶,Resta O³,Carpagnano GE³^ORCID,Palmieri VO⁴,Vacca A²^ORCID,Dell’Aera M⁷,Dell’Erba A⁵,Migliore G⁸,Aricò M⁹,Saracino A¹

Affiliation:

1. Clinic of Infectious Diseases, Department of Biomedical Sciences and Human Oncology, University of Bari “Aldo Moro”, Bari, Italy

2. Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine ‘G. Baccelli’ University Hospital Policlinico, Bari, Italy

3. Department of Basic Medical Science, Institute of Respiratory Disease, Neuroscience, and Sense Organs, University of Bari “Aldo Moro”, Bari, Italy

4. Clinica Medica ‘A. Murri’, Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, Bari, Italy

5. Interdisciplinary Department of Medicine, University of Bari – Section of Legal Medicine, Bari General Hospital, Bari, Italy

6. Section of Health Management, Policlinico Hospital, Bari, Italy

7. Hospital Pharmacy, Direttore Farmacia Ospedaliera Aou Policlinico Di Bari, Bari, Italy

8. General Direction, Policlinico Hospital, Bari, Italy

9. Strategic Direction, Policlinico Hospital, Bari, Italy

Funder

work featured in this article

Publisher

Informa UK Limited

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Medicine,Microbiology,Parasitology

Link

https://www.tandfonline.com/doi/pdf/10.1080/20477724.2021.2024030

Reference27 articles.

1. Peculiar clinical presentation of COVID-19 and predictors of mortality in the elderly: A multicentre retrospective cohort study

2. The mortality rate of COVID-19 was high in cancer patients: a retrospective single-center study

3. Targeted therapies for autoimmune/idiopathic nonmalignant diseases: risk and management of opportunistic infections

4. COVID-19: immunopathogenesis and Immunotherapeutics

5. Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiology and clinical management of coronavirus disease (COVID-19): a mini-review;Frontiers in Immunology;2023-08-14

2. Use of Monoclonal Antibodies in Pregnant Women Infected by COVID-19: A Case Series;Microorganisms;2023-07-31

3. Determinants of COVID-19 Disease Severity–Lessons from Primary and Secondary Immune Disorders including Cancer;International Journal of Molecular Sciences;2023-05-14

4. Electrocardiographic Pathological Findings Caused by the SARS-CoV-2 Virus Infection: Evidence from a Retrospective Multicenter International Cohort Longitudinal Pilot Study of 548 Subjects;Journal of Cardiovascular Development and Disease;2023-01-31

5. Lung Ultrasound Is Useful for Evaluating Lung Damage in COVID-19 Patients Treated with Bamlanivimab and Etesevimab: A Single-Center Pilot Study;Medicina;2023-01-19